5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
The 2011 ASCO (American Society of Clinical Oncology) Annual Meeting - Post Conference Review and Analysis
5-Hydroxytryptamine Receptor 6 Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2021 Update